Navigation Links
Artery Stiffness Linked To Increasing Levels Of C-reactive protein

Mayo Clinic researchers have shown that increased levels of C-reactive protein in the blood are associated with the stiffening of the arteries.

This finding could lead to new and improved // public health strategies to prevent heart disease, such as developing drugs that suppress inflammation to improve the health of arteries before full-blown heart disease develops.

The Mayo Clinic research report appears online and in the August issue of the American Journal of Hypertension.

The Mayo Clinic collaborative study with researchers from the University of Michigan looked at 214 men and women with an average age of 59, who had no history of heart attack or stroke. Results suggest that low-grade inflammation is associated with arterial stiffness (hardening). This inflammation may be a potential mechanism through which C-reactive protein is related to heart attack and stroke, and why testing for C-reactive protein in a blood test may be an effective early warning test for asymptomatic, or presymptomatic heart disease.

Researchers around the world agree that C-reactive protein is associated with increased risk of heart attack and stroke. But it remains controversial whether C-reactive protein is a risk factor that affects the function of blood vessels, or if it is simply a marker signifying the presence of disease.

In addition to taking into account the traditional risk factors for heart disease—such as male sex, presence of diabetes, high blood pressure, high cholesterol and smoking—the research team also measured C-reactive protein levels as well as three indicators of arterial stiffness. Stiffening of arteries indicates a loss of their elastic properties and predisposes to heart attack, stroke and congestive heart failure.

The current inability to accurately predict cardiovascular events such as heart attack is a problem. The researchers said that their study provides a new insight into how low grade i nflammation could be related to heart and stroke by its association with arterial stiffness. Thus suppression of inflammation may be a target of drug therapy to improve arterial health.

Source: Newswise
'"/>




Related medicine news :

1. Transdermal HRT not cardioprotective in postmenopausal women with Coronary Artery Disease
2. The Link Between Oxidized Phospholipids And Coronary Artery Disease
3. Stents That Release Medication To Check Artery Narrowing
4. Cigarette Smoking Leads To Development Of Type 2 Diabetes In Patients With Coronary Artery Disease
5. Stenting: A Possible Remedy For Brain Artery Blockage
6. Peripheral Artery Disease Can Be Delayed By Walking
7. Neck Artery Treatment Apart From Clearing Plaques Boosts Memory
8. Physical Activity benefited Peripheral Artery Disease (PAD) patients
9. Patient’s Individual Cardiologist Best Judge For Deciding Appropriate Treatment In Chronic Coronary Artery Diseas
10. Methamphetamine Use Increases Risks of Artery Tears and Stroke
11. Early Detection of Artery Weakening Can Be a Life-Saver
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/10/2016)... ... February 10, 2016 , ... The 9th annual meeting ... Congress (WMIC), will be held in New York City, NY on September 7 ... The congress will highlight and emphasize how imaging reveals a greater understanding of ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... ... working together to expand dental health services to the developmentally disabled in the ... Care Dental’s operations to a new facility at 71-949 Highway 111, Suite 100-B, ...
(Date:2/10/2016)... ... 10, 2016 , ... Compliancy Group LLC is pleased to ... throughout the country. The Guard was specifically designed to handle each element required ... regulatory updates, and compliance coaching. , In addition to meeting the compliance needs ...
(Date:2/10/2016)... ... ... Dr. Jessica Barron, of Barron Family Dental in Thornton, Colorado , ... in the North Metro Denver area. The new dental practice focuses on comfort where ... in the most relaxing environment. , While some dental visits can create anxiety for ...
(Date:2/10/2016)... ... February 10, 2016 , ... AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology ... quarter and full year ended December 31, 2015 on Monday, February 29, 2016 after ... the investment community following the release at 4:30 PM ET. Investors interested in participating ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... England och PITTSBURGH ... Erbjudandet lämnas inte, och detta pressmeddelande ... indirekt, i eller till, och inga anmälningssedlar ... av aktieägare i, något land där Erbjudandet, ... accept av Erbjudandet skulle strida mot tillämpliga ...
(Date:2/10/2016)... February 10, 2016 A new report from business intelligence ... states that the Alzheimer,s disease market will more than double from just under ... Compound Annual Growth Rate (CAGR) of 11%. Canada , ... , Spain , the UK, and Japan ... forecast period. --> Canada , France ...
(Date:2/10/2016)... , Feb. 10, 2016 Urologix, the ... the treatment of Benign Prostatic Hyperplasia (BPH), announces new ... Ash Keswani , a medical device industry veteran of ... the Limited Liability Company.  Plymouth, ... service lines, Cooled ThermoTherapy™ and Prostiva® RF Therapy, will ...
Breaking Medicine Technology: